Budget Amount *help |
¥4,160,000 (Direct Cost: ¥3,200,000、Indirect Cost: ¥960,000)
Fiscal Year 2010: ¥1,170,000 (Direct Cost: ¥900,000、Indirect Cost: ¥270,000)
Fiscal Year 2009: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2008: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Research Abstract |
We evaluated the influence of HBc antibody seropositivity in (1) the recurrence of non-B non-C hepatocellular carcinoma (HCC) after curative treatment, (2) in the development of HCC among patients with non-B non-C chronic liver disease, and (3) in the development of HCV-related HCC. HBc antibody positivity was found to be a significant risk factor in none. Serum HBV load was associated with the risk of recurrence of HBV-related HCC.
|